For the majority of cases, NRAS mutations are missense mutations of codons 12, 13, and 61, all of which influence GTPase activity; however, mutations to codon 61 alone account for up to 80% of NRAS mutations in cutaneous melanoma disease [104]. Here, NRAS is linked to cutaneous melanoma.